Magnetar Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,760
| Closed | -$352K | – | 771 |
|
|
2022
Q3 | $352K | Sell |
1,760
-14,627
| -89% | -$2.93M | ﹤0.01% | 867 |
|
|
2022
Q2 | $2.39K | Buy |
+16,387
| New | +$2.39K | 0.02% | 604 |
|
|
2021
Q2 | – | Sell |
-1,980
| Closed | -$280K | – | 1186 |
|
|
2021
Q1 | $280K | Sell |
1,980
-1,628
| -45% | -$230K | ﹤0.01% | 932 |
|
|
2020
Q4 | $469K | Buy |
+3,608
| New | +$469K | 0.01% | 572 |
|
|
2018
Q2 | – | Sell |
-4,603
| Closed | -$548K | – | 487 |
|
|
2018
Q1 | $548K | Buy |
+4,603
| New | +$548K | 0.01% | 311 |
|
|
2015
Q4 | – | Sell |
-5,612
| Closed | -$451K | – | 326 |
|
|
2015
Q3 | $451K | Buy |
5,612
+3,369
| +150% | +$271K | 0.01% | 204 |
|
|
2015
Q2 | $269K | Buy |
+2,243
| New | +$269K | ﹤0.01% | 338 |
|